CSDE1 depletion inhibits tumor progression through enhancing B-cell infiltration in NSCLC
Open Access
- 6 December 2025
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1)
Abstract
Although most immunotherapy research focuses on T cells, increasing evidence highlights the significant role of tumor-infiltrating B lymphocytes (TIL-Bs) in cancer therapy. CSDE1 has been implicated in various cancers and immune responses. This study investigates the role of CSDE1 in lung cancer progression and its impact on the tumor immune microenvironment. We found that CSDE1 promotes lung cancer progression in vivo but not in vitro. Using the tumor-bearing mice model with Csde1 knockout, we demonstrated that Csde1 deletion significantly inhibited tumor growth. Single-cell RNA sequencing revealed that Csde1 knockout reshaped the tumor immune microenvironment, particularly by significantly increasing TIL-B levels, a finding confirmed by flow cytometry and immunofluorescence. Moreover, Csde1 knockout enhanced B-cell-mediated humoral immunity. Notably, depleting B cells in Csde1 knockout mice reversed the inhibitory effect of Csde1 deletion on tumor progression, underscoring the critical role of B cells in this process. These findings suggest that CSDE1 facilitates tumor progression by modulating TIL-Bs and the broader immune microenvironment. This study provides a new potential target and valuable insights into tumor immunotherapy, emphasizing the importance of B cells in cancer treatment strategies.Keywords
This publication has 36 references indexed in Scilit:
- Lung cancer statistics, 2023Cancer, 2024
- Tumor-infiltrating regulatory T cells as targets of cancer immunotherapyCancer Cell, 2023
- B cells in the tumor microenvironment: Multi-faceted organizers, regulators, and effectors of anti-tumor immunityCancer Cell, 2023
- Single‐cell transcriptome analysis reveals functional changes in tumour‐infiltrating B lymphocytes after chemotherapy in oesophageal squamous cell carcinomaClinical and Translational Medicine, 2023
- Microenvironment-driven metabolic adaptations guiding CD8+ T cell anti-tumor immunityImmunity, 2023
- An Integrated Multi-omic Single-Cell Atlas of Human B Cell IdentityImmunity, 2020
- UNR/CSDE1 Drives a Post-transcriptional Program to Promote Melanoma Invasion and MetastasisCancer Cell, 2019
- B Cell Responses: Cell Interaction Dynamics and DecisionsCell, 2019
- Oral squamous cell carcinoma: Key clinical questions, biomarker discovery, and the role of proteomicsArchives of Oral Biology, 2016
- Pheochromocytoma and ParagangliomaHematology/Oncology Clinics of North America, 2016